Please provide your email address to receive an email when new articles are posted on . 42.6% of patients filled a SABA prescription 30 days before an exacerbation, and 61.4% did so within 30 days ...

Adolescents with overweight or obesity and asthma had a lower risk of asthma exacerbations after starting a GLP-1 receptor agonist, a retrospective cohort study found.

Providers from an asthma primary care program found telemedicine to be effective in both caring for children with asthma and addressing unmet social needs that may exacerbate their asthma outcomes.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Children with uncontrolled, moderate to severe asthma ...

Children treated with dupilumab showed improved lung function compared with placebo group, according to one study. Children with asthma treated with dupilumab showed significantly improved lung ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AIRSUPRA’s US Prescribing Information now includes clinically meaningful evidence from the BATURA study in patients with mild asthma. 1 The BATURA Phase IIIb trial, ...

The global trial met its primary endpoint showing both doses of rademikibart treatment significantly improved lung function at Week 12 The significant improvement in lung function was observed as ...

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 VOYAGE trial. The Food and Drug Administration (FDA) has expanded the approval of Dupixent ® (dupilumab) to ...

ORLANDO — Clinicians commonly recommend that the dose of inhaled glucocorticoids be quintupled when patients start losing control of their asthma, but this strategy fails to prevent exacerbations in ...

In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11. The findings of the ...